Securities Class Action
Search documents
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
TMX Newsfile· 2026-02-25 00:34
New York, New York--(Newsfile Corp. - February 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public.SO WHAT: If you purchased PennyMac securities you may be entitled to compensation without payment of any out of pocket fees or costs through a ...
RGNX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026
TMX Newsfile· 2026-02-24 22:16
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In REGENXBIO To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in REGENXBIO between February 9, 2022 and January 27, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - February ...
RARE UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
TMX Newsfile· 2026-02-24 22:10
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ultragenyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ultragenyx between August 3, 2023 and December 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - February ...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Oracle Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - ORCL
TMX Newsfile· 2026-02-24 20:14
New York, New York--(Newsfile Corp. - February 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Oracle Corporation (NYSE: ORCL) between June 12, 2025, and December 16, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 6, 2026.SO WHAT: If you purchased Oracle common stock during the Class Period y ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages PayPal Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PYPL
TMX Newsfile· 2026-02-24 19:44
New York, New York--(Newsfile Corp. - February 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PayPal Holdings, Inc. (NASDAQ: PYPL) between February 25, 2025 and February 2, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026.SO WHAT: If you purchased PayPal common stock during the Class ...
MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026
TMX Newsfile· 2026-02-24 01:17
Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Mereo BioPharma Group plc due to alleged violations of federal securities laws related to misleading statements about clinical trial results [2][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Mereo BioPharma to contact them to discuss their legal options [1]. - There is a deadline of April 6, 2026, for investors to seek the role of lead plaintiff in a federal securities class action against Mereo [2][7]. Group 2: Clinical Trial Results - Mereo announced that two Phase 3 studies of setrusumab failed to meet their primary endpoints of reducing annualized clinical fracture rates compared to placebo and bisphosphonates [5]. - Despite the failure to meet primary endpoints, the trials showed statistically significant improvements in bone mineral density on secondary endpoints, and no new safety concerns were identified [5]. Group 3: Market Reaction - Following the announcement of the failed trials, Mereo's stock price fell by $2.02 per share, or 87.64%, closing at $0.28 per share on December 29, 2025 [6].
ROSEN, NATIONALLY RANKED INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMR
TMX Newsfile· 2026-02-24 00:44
Core Viewpoint - A class action lawsuit has been filed against NuScale Power Corporation on behalf of purchasers of its Class A common stock between May 13, 2025, and November 6, 2025, due to alleged misleading statements and undisclosed risks related to its commercialization strategy [1][5]. Group 1: Lawsuit Details - The lawsuit claims that NuScale's partner, ENTRA1 Energy LLC, had no significant experience in building or operating nuclear power projects, which was not disclosed to investors [5]. - It is alleged that NuScale misrepresented the qualifications of ENTRA1, attributing experience to the Habboush Group, which also lacked relevant expertise in nuclear power generation [5]. - The lawsuit asserts that these misrepresentations exposed NuScale's commercialization strategy to undisclosed risks, leading to investor damages when the truth was revealed [5]. Group 2: Participation Information - Investors who purchased NuScale Class A common stock during the specified period may be eligible for compensation without any out-of-pocket costs through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by April 20, 2026, to represent the interests of the class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm, which is leading the class action, has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its success in securities class action settlements and has consistently ranked among the top firms in this area since 2013 [4].
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR
Globenewswire· 2026-02-23 20:26
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026. SO WHAT: If you purchased NuScale Class A common stock during the Class P ...
CRWV Investors Encouraged to Seek Lead Plaintiff Role in CoreWeave Securities Class Action with Johnson Fistel
Globenewswire· 2026-02-23 16:58
Core Points - A class action lawsuit has been filed against CoreWeave, Inc. for alleged securities fraud during the Class Period from March 28, 2025, to December 15, 2025 [1] - Investors who purchased CoreWeave securities during this period and suffered losses have until March 13, 2026, to seek appointment as lead plaintiff [2] - The lawsuit claims that CoreWeave made misleading statements regarding its ability to meet customer demand and the risks associated with reliance on a single third-party data center supplier [4] Allegations - CoreWeave is accused of overstating its capacity to meet customer demand for its AI cloud computing services [4] - The company allegedly failed to disclose the significant risks posed by its dependence on a single third-party data center, which could negatively impact its revenue [4] - The lawsuit suggests that these misrepresentations led to substantial losses for investors when the truth was revealed [5] Company Background - CoreWeave is positioned as an AI cloud computing company and announced a significant deal worth up to $11.9 billion with OpenAI shortly before its IPO [3] - The company also announced an agreement to acquire Core Scientific, a major player in digital infrastructure for high-performance computing, in an all-stock transaction [3]
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Apollo Global Management, Inc. Investors to Inquire About Securities Class Action Investigation - APO
TMX Newsfile· 2026-02-23 03:15
Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Apollo Global Management, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by an article from Financial Times stating that Apollo executives, including CEO Marc Rowan, had discussions regarding tax arrangements with Jeffrey Epstein, despite previous claims of no business dealings with him [3]. - Following the news, Apollo's stock experienced a decline of 1% on February 2, 2026, and a further drop of 4.76% on February 3, 2026 [3]. Group 2: Class Action Information - Shareholders who purchased Apollo securities may be eligible for compensation through a class action lawsuit without any out-of-pocket fees, facilitated by a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].